Tweet
Originally posted by New-born baby
I would also take a look at Cell Theraputics (CTIC). A cheap little sleeper at $1.90, could pick up some traction and turn into a $3 stock before you know it.
-
You are 100% dead on with the GOOG options. You should see some steady movement from SNY, not only today, but the coming weeks as well. Nice picks.
I would also take a look at Cell Theraputics (CTIC). A cheap little sleeper at $1.90, could pick up some traction and turn into a $3 stock before you know it. -
BTW- CTIC is definitely a contrarian pick.Comment
-
CTIC up at noon 3 3/4% to 1.98, 7 cents off it intraday high of 2.05.Originally posted by Adman
One worth watching.Comment
-
ERS revisited
Here's what happened to ERS since I wrote the above comments: she never broke out above the $22.50 mark. Instead, she fell down. Now it appears the symmetrical triangle has been broken to the downside, and ERS is due for a correction. That correction may very well become an excellent buying opportunity. See this:http://www.financialexpress.com/fe_f...tent_id=120127Originally posted by New-born babyERS:no option chain. On the very cusp of busting out into the Twilight Zone. No identifiable target . . . if you enter now, place a stop under it and see what happens. Nervous Nellies making long North and South wicks on the candles the last three weeks. Volume is delightful. Could really zoom higher now; could tank if someone discovers a replacement for crude oil in the next day.
PLAY #1: Buy the breakout above the $22.50 mark; target $29; place stop under previous day's LOD. If that is .50, the r/r ratio is 13:1. Excellent!
Daily: click on image, click once or twice more to enlarge.
Weekly:
Until then, the current plan is short. The chart says that the immediate target should be $11-12. ERS has beautifully bounced up close to the symmetrical triangle's lower base line. When she touches that line, it is time to short her down. I'd be looking to short any strength in this one.
Comment
-
DXPE Revisited
No breakout just yet, and patience is the only way to play this one. May change my mind from bullish to bearish. The red volume sticks are longer that the black ones. Up Friday on lower than average volume: trouble ahead.Originally posted by New-born babyVery, very nice bullish gap up on Thursday with solid Friday follow through. Powerful volume bursts. Has a nice big $31+ target (could even hit $40-$45). . . current price $23.71. Has a price resistance at $25, and after that, "The Twilight Zone!" (i.e. no overhead resistance). If DXPE can bust out of the $25 resistance it could run like Shaun Alexander in the open field. Another beautiful Ninner pick: solid fundys with lots of room to grow. Unfortunately no option chain.
How to play it:
Play #1: The patient play is to wait for the ascending triangle to breakout, and to buy the direction of the breakout. That direction should be to the upside. Huge target of $31+, with exit stop at just below the breakout support line (i.e. $25.20). You risk about .20 with a target gain of $6.20, for a risk/reward ratio of 31. WHAT IS WRONG WITH THAT? Just another day at the salt mine for Ninner! Nice pick!
You do know to click on the image below; then click once or more to enlarge it to your taste
The weekly:
Comment
-
No breakout yet for sure. TALX broke down to the $30 mark and looks like a decent place to enter right here with stop at $29.76. Current price is $30.14, so that risks $.38 with first target of $36, second target $45. Outstanding r/r ratio of 15.78/1 and 39.47/1. What's wrong with that?Originally posted by New-born babyTALX: another Ninner pick;has a relatively decent option chain. Just exploded out of a minor cup with handle. Target is $45--a nice $10 gain expectation on a $35 stock . . . that's looking for a 28.5% gain. Another possible entry for the Twilight Zone (no overhead resistance after $36.50!). Weekly chart working on a ascending triangle breakout. Just beautiful action on the weekly. The daily shows a shakeout of weak holders last week before Thursday's breakout.
PLAY #1: Buy the breakout above $36.50 with a stop under the previous day's Low of the Day. Let's suppose that is a stop loss of .50; target is $45, a risk of .50 for the reward of $8.50, a ratio of 17/1--what's wrong with that?
Excellent pick, Ninner!
Daily chart: click on image, then click once or more to enlarge.
Weekly:
http://img96.imageshack.us/img96/5369/chart27ib.gifComment
-
ERS bullish engulfing signal
have to see what tommorrow brings but tomorrow is the last day for a confirmation of the signal..we will see if ERS can break through the new resistance level.
cheers
Originally posted by New-born babyHere's what happened to ERS since I wrote the above comments: she never broke out above the $22.50 mark. Instead, she fell down. Now it appears the symmetrical triangle has been broken to the downside, and ERS is due for a correction. That correction may very well become an excellent buying opportunity. See this:http://www.financialexpress.com/fe_f...tent_id=120127
Until then, the current plan is short. The chart says that the immediate target should be $11-12. ERS has beautifully bounced up close to the symmetrical triangle's lower base line. When she touches that line, it is time to short her down. I'd be looking to short any strength in this one.
Comment
-
New Born BMRN I like what IC
New Born BMRN seems as if it is ready to bounce off its 20 Day EMA ......any thoughts on this one?Comment
-
Bmrn
Pete,Originally posted by Peter Hansen
Thanks for posting. I apologize that sometimes in the past I have been slow to post a chart. The reason is NOT that I don't like you--man, I like your picks!--but most often it is due to me being out of the office. I am very sorry and I apologize for the pathetically slow responses.
Here's what I see: decent option chain for a $12 stock. The action the past few days was the usual retest of the recent breakout. She broke out on FEB 24 and she came back to rest the $12 support level. Has built a strong base along this $12 mark, and would have been the best place to look for a long entry. PnF says $18.50 is realistic over time; six month channel agrees. STOs say that BMRN could turn the corner and rise today.
In summary: if you are in the stock I see no reason to leave. If you want in, I'd be looking $12 for the entry, with the knowledge that she has some $13 resistance.
My style of trading tells me that if you get 10% out of a sub $20 stock, you take it and come back if you like on a retest of lower support levels. This stocks price action of two steps forward, one and three-quarter steps back, shows the proof of that strategy.
Best to you, Pete!
Comment
-
New Born
Once Again......thanx for an excellent analysis of BMRN .......I think you are right to wait for 12 price..... Nb I am an easy going guy and dont worry about much .........why worry..... nobody is leaving this world alive anyway ...LOL
Pretty much live each day as if it were your last day ........and one day .......You will be right !Comment
-
ERS rerevisited
looking strong today the bullish engulfing signal from Thursday was confirmed today!!!Comment
-
Thursday's open was the same as Wednesday's close (17.73), so no bullish engulfing candlestick.Originally posted by ninnerComment
-
bullish engulfing by defn
a bullish engulfing signal can include......either the open or the close being equal to the open or close of the previous day but not both.....so since the open on thursday was equal to the open on wed but engulfed the close of wed...i still intrepret this as being a engulfing signal......Comment
-
wow....had a great day today with ADAM,VTAL,ERS....my only dog was TALX which stayed pretty much the same...didnt really expect this on a disappointing market day.
cheers everyone.Comment
-
I know . . . .
Ninner,Originally posted by ninner
I know you may not like this very much, but ERS looks like a short from here to me. What we had today was a retest of the lower symmetrical triangle. My plan would be to short her tomorrow a few minutes after the open and put a protective stop above it. Sounds crazy to you, doesn't it?
Best to you, Ninner!Comment
Comment